Nerai Bioscience

Nerai Bioscience is at the forefront of biotechnology research, advancing genome editing with a new generation of ultra-precise CRISPR enzymes. Engineered to unlock genomic targets beyond the reach of existing technologies, Nerai Bioscience is dedicated to creating a world where no genetic disease is too rare, too hard, or too complex to cure.

Located in Zurich, at Dorfstrasse, Nerai Bioscience’s proprietary MORPHEME platform combines AI and high-throughput protein engineering via directed evolution to design bespoke genome editors with unmatched specificity and therapeutic potential. Nerai Bioscience doesn’t just edit DNA—they aim to rewrite the future of patients through innovative solutions and a commitment to excellence.

Nerai Bioscience is committed to pushing the boundaries of what's possible in genome editing, with a focus on precision and therapeutic potential. The company is actively expanding its reach and impact within the biotechnology sector, and additional information regarding Nerai Bioscience will be completed soon with the support of the company’s management. We invite the manager of Nerai Bioscience to create a customized and exclusive company showcase and product listing on our platform.